WallStreetZenWallStreetZen

NYSE: ADCT
Adc Therapeutics Sa Stock Ownership - Who owns Adc Therapeutics Sa?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Adc Therapeutics Sa insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter HugDirector2026-06-032,156$3.08
$6.64kSell
Jeanpierre BizzariDirector2026-06-0312,600$3.08
$38.81kSell
Robert AzelbyDirector2026-06-0312,600$3.08
$38.81kSell
Viviane MongesDirector2026-06-032,596$3.08
$8.00kSell
Ron SquarerDirector2026-06-0315,196$3.08
$46.80kSell
Timothy CoughlinDirector2026-06-0312,600$3.08
$38.81kSell
Victor SandorDirector2026-06-0312,600$3.08
$38.81kSell
Redmile Group LLC10% Owner2026-04-022,529,491$3.28
$8.29MSell
Redmile Group LLC10% Owner2026-04-022,634,506$3.28
$8.64MSell
Redmile Group LLC10% Owner2026-04-01162,517$3.80
$617.40kSell

1 of 3

ADCT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ADCT insiders and whales buy or sell their stock.

ADCT Shareholders

What type of owners hold Adc Therapeutics Sa stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Redmile Group LLC30.35%38,598,759$45.93MInsider
Redmile Group LLC12.16%15,470,502$18.41MInstitution
Tcg Crossover Management LLC8.96%11,390,175$13.55MInstitution
Hans Peter Wild7.70%9,788,944$11.65MInsider
Prosight Management LP6.53%8,300,000$9.88MInstitution
Blackrock Inc4.91%6,250,747$7.44MInstitution
Eventide Asset Management LLC4.48%5,701,655$6.78MInstitution
Nantahala Capital Management LLC4.40%5,597,433$6.66MInstitution
Morgan Stanley3.00%3,812,582$4.54MInstitution
Point72 Asset Management LP2.66%3,382,129$4.02MInstitution

1 of 3

ADCT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ADCT60.01%39.99%Net SellingNet Selling
UNCY37.10%17.14%
MOLN9.57%0.00%
MSLE38.33%0.00%
CNTB20.25%22.08%Net BuyingNet Buying
View Top Biotech Stocks

Adc Therapeutics Sa Stock Ownership FAQ

Who owns Adc Therapeutics Sa?

Adc Therapeutics Sa (NYSE: ADCT) is owned by 65.66% institutional shareholders, 43.75% Adc Therapeutics Sa insiders, and 0.00% retail investors. Redmile Group LLC is the largest individual Adc Therapeutics Sa shareholder, owning 38.60M shares representing 30.35% of the company. Redmile Group LLC's Adc Therapeutics Sa shares are currently valued at $45.93M.

If you're new to stock investing, here's how to buy Adc Therapeutics Sa stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.